Navigation Links
Experts Examine the Success of Cognitive Behavioral Therapy in Treating Depression Among Older Veterans
Date:11/5/2013

New York, NY (PRWEB) November 05, 2013

Researchers have found significant and equivalent reductions in depressive symptoms for both older and younger veterans undergoing Cognitive Behavioral Therapy for depression (CBT-D), according to an article to be published in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences on November 11.

This study, led by Dr. Bradley Karlin at the U.S. Department of Veterans Affairs, is among the first to compare changes in depression and quality of life and to examine the therapeutic alliance in both younger and older adults, and to do so using a large, diverse national sample of veterans.

Previous studies have found that older adults utilize mental health services at very low rates, substantially lower than those documented for younger individuals.

“Untreated depression in older adults is associated with poorer quality of life, significantly increased mortality, increased suicide rates, exacerbation of and/or delay in recovery from medical illness, and considerable economic, social, family, and overall societal costs,” the authors state.

They add that this evaluation demonstrates the promise and effectiveness of CBT-D in counteracting depression and provides encouragement to older adults in seeking treatment.

Karlin’s team analysed the effectiveness of CBT-D among 864 older (age 65 and over) and younger (age 18 to 64) veterans seeking treatment within the Veterans Health Administration. The CBT-D treatment protocol was developed specifically for veterans and military service members and is intended to be administered in approximately 12 to 16 individual psychotherapy sessions.

Approximately 68 percent of both older and younger patients completed all sessions or finished early due to symptom relief. Of those, there was an average overall reduction of close to 40 percent in Beck Depression Inventory-II scores — used to assess the severity of depression — from the early phase to the later phase of treatment.

The paper, “Comparison of the Effectiveness of Cognitive Behavioral Therapy for Depression among Older Versus Younger Veterans: Results of a National Evaluation,” is available upon request.

For more information or to interview one of the authors, please contact:
Alana Podolsky | Publicity | alana.podolsky(at)oup(dot)com | 212-726-6057

The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences is published by Oxford University Press on behalf of The Gerontological Society of America. Attribution to The Journals of Gerontology, Series B: Psychological Sciences is requested in all news coverage.

Oxford Journals is a division of Oxford University Press. We publish well over 300 academic and research journals covering a broad range of subject areas, two-thirds of which are published in collaboration with learned societies and other international organizations. We have been publishing journals for more than a century, and as part of the world’s oldest and largest university press, have more than 500 years of publishing expertise behind us.

Sharing on social media? Find Oxford Journals online at @OxfordJournals.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11303288.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Experts Offer Advice After Yankee Pitchers Trampoline Injury
2. NYU Langone experts present research, clinical advances at neurosurgeons meeting
3. Red Tide Likely in New England This Season, Experts Warn
4. No Proof That Gum Disease Causes Heart Disease, Experts Say
5. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
6. Glaucoma Need Not Steal Sight, Experts Say
7. Healthy Behaviors Extend Life After Cancer, Experts Say
8. Routine Kidney Disease Screening Not Worthwhile, Experts Say
9. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
10. Aim Skin Cancer Warnings at the Young, Too, Experts Say
11. Experts call for clinical trials to test non-skeletal benefits of vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... ... financial planning assistance to families and business owners in and around the Hampton ... drive to help prevent all forms of domestic violence. , There are multiple ...
(Date:2/16/2017)... , ... February 17, 2017 , ... ... what took over 10 years of research, development and clinical trials, the founder ... Technology™ is a patented compound of FDA approved ingredients that when infused into ...
(Date:2/16/2017)... ... 2017 , ... Teaching nursing care of vulnerable children is the focus of ... being created with the support of the Hearst Foundations. An initiative of the ... what has been identified as a critical gap in preparing the next generation of ...
(Date:2/16/2017)... Kisco, New York (PRWEB) , ... February 16, ... ... Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH has ... of the Commission on Magnet on Tuesday, January 31, 2017. The American Nurses ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... doegedevelopment.com/contact/ , doegedevelopment.com , David A Doege is excited to announce ... commercial tenant improvements, ground up new builds, design build, and site improvements. , ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017   FormFast , the leader ... new partnership with Engage , one of the ... . FormFast will serve as the forms automation ... with MEDITECH .  FormFast is ... to complement and enhance the electronic health record. FormFast,s ...
(Date:2/17/2017)... , Feb. 17, 2017  BioDigital, Inc., ... the partnership of their 3D body mapping technology ... IT.  The new integration will be used to ... interactive model of the human body. BioDigital pilots ... clinicians time, while also increasing the precision of ...
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
Breaking Medicine Technology: